Mechanisms of the Release of 3H-noradrenaline by Dimethylphenylpiperazinium (DMPP) in the Rat Vas Deferens

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1990 Jan 1

PMID 2314482

Citations 3

Authors

M Niebler

U Trendelenburg

Affiliations

Soon will be listed here.

Abstract

In the rat vas deferens, DMPP is a substrate of uptake1 (Km = 11.5 mumol/l). After block of vesicular uptake, monoamine oxidase and catechol-O-methyl transferase, after loading of the tissue with 3H-noradrenaline, and in calcium-free solution (i.e., when axoplasmic 3H-noradrenaline levels were high and when depolarization-induced exocytotic release was impossible), DMPP induced a pronounced outward transport of 3H-noradrenaline. On the other hand, when, in similar experiments, vesicular uptake and monoamine oxidase were intact (i.e., when axoplasmic 3H-noradrenaline levels were low), DMPP induced very little outward transport of 3H-noradrenaline. This discrepancy indicates that DMPP has little ability to mobilize vesicularly stored 3H-amine. When the medium contained calcium (catechol-O-methyl transferase inhibited, all other mechanisms intact), 100 (but not 10) mumol/l DMPP induced a hexamethonium-sensitive release of 3H-noradrenaline of short duration. Hence, in the presence of extracellular calcium, 100 mumol/l DMPP elicits exocytotic release via activation of hexamethonium-sensitive nicotinic acetylcholine receptors. DMPP inhibits the monoamine oxidase of rat heart homogenate with an IC50 of about 100 mumol/l.

Citing Articles

Functional neurochemical evidence for the presence of presynaptic nicotinic acetylcholine receptors at the terminal region of myenteric motoneurons: a study with epibatidine.

Mandl P, Kiss J, Vizi E Neurochem Res. 2003; 28(3-4):407-12.

PMID: 12675123 DOI: 10.1023/a:1022884231313.

Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices.

Kiss J, Windisch K, De Oliveira K, Hennings E, Mike A, Szasz B Neurochem Res. 2001; 26(8-9):943-50.

PMID: 11699946 DOI: 10.1023/a:1012384517784.

The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

Schomig E, Schonfeld C, Halbrugge T, Graefe K, Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(2):160-70.

PMID: 2234101 DOI: 10.1007/BF00166959.

References

Schomig E, Trendelenburg U . Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(6):631-40. DOI: 10.1007/BF00165753. View

Loffelholz K . Nicotinic drugs and postganglionic sympathetic transmission. Naunyn Schmiedebergs Arch Pharmakol. 1970; 267(1):64-73. DOI: 10.1007/BF00997115. View

Haeusler G, Haefely W, HUERLIMANN A . On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn Schmiedebergs Arch Pharmakol. 1969; 265(3):260-77. DOI: 10.1007/BF01002340. View

Langeloh A, Bonisch H, Trendelenburg U . The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(6):602-10. DOI: 10.1007/BF00165750. View

Graefe K, Trendelenburg U . The effect of hydrocortisone on the sensitivity of the isolated nictitating membrane to catecholamines: Relationship to extraneuronal uptake and metabolism. Naunyn Schmiedebergs Arch Pharmacol. 1974; 286(1):1-48. DOI: 10.1007/BF00499103. View

Graffe K, STEFANO F, Langer S . Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol. 1973; 22(10):1147-60. DOI: 10.1016/0006-2952(73)90231-1. View

LINDMAR R, Loffelholz K, Muscholl E . [Differences between tyramine and dimethylphenylpiperazine in the Ca++-dependency and in the temporary course of noradrenaline release from the isolated rabbit heart]. Experientia. 1967; 23(11):933-4. DOI: 10.1007/BF02136230. View

Langeloh A, Trendelenburg U . The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(6):611-20. DOI: 10.1007/BF00165751. View

Schomig E, Fischer P, Schonfeld C, Trendelenburg U . The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(5):502-8. DOI: 10.1007/BF00260604. View

10.

Grohmann M, Trendelenburg U . The substrate specificity of uptake2 in the rat heart. Naunyn Schmiedebergs Arch Pharmacol. 1984; 328(2):164-73. DOI: 10.1007/BF00512067. View

11.

Kuntzman R, JACOBSON M . MONOAMINE OXIDASE INHIBITION BY A SERIES OF COMPOUNDS STRUCTURALLY RELATED TO BRETYLIUM AND GUANETHIDINE. J Pharmacol Exp Ther. 1963; 141:166-72. View

12.

Trendelenburg U, STEFANO F, Grohmann M . The isotope effect of tritium in 3H-noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1983; 323(2):128-40. DOI: 10.1007/BF00634260. View

13.

Loffelholz K . Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves. Naunyn Schmiedebergs Arch Pharmakol. 1970; 267(1):49-63. DOI: 10.1007/BF00997114. View

14.

Holbach H, LINDMAR R, Loffelholz K . DMPP and the adrenergic nerve terminal: mechanisms of noradrenaline release from vesicular and extravesicular compartments. Naunyn Schmiedebergs Arch Pharmacol. 1977; 300(2):131-8. DOI: 10.1007/BF00505043. View

15.

Schonfeld C, Trendelenburg U . The release of 3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in alpha-position. Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(4):433-40. DOI: 10.1007/BF00736058. View